Skip to main navigation
Toggle navigation
About Us
Who We Are
Management Team
Founders
Board of Directors
Core Values
In The News
Our Approach
& Programs
Gene Therapy
Pipeline
Our Programs
Manufacturing
Publications
Patients
& Caregivers
About Gene Therapy
Parkinson’s Disease FAQ
Our Clinical Trials
Patient Resources
For Investors
& Media
Investor Overview
Stock Information
Stock Quote
Stock Chart
Press Releases
Events and Presentations
Event Calendar
Past Events
Presentations
Corporate Governance
Management
Board of Directors
Committee Composition
Documents & Charters
Contact the Board
Financial Information
SEC Filings
Annual Reports
Analyst Coverage
Investor FAQs
Contact Us
Join
Our Team
Who We Are
Benefits
Join Us
Awards
Contact
Toggle navigation
About Us
Who We Are
Management Team
Founders
Board of Directors
Core Values
In The News
Our Approach
& Programs
Gene Therapy
Pipeline
Our Programs
Manufacturing
Publications
Patients
& Caregivers
About Gene Therapy
Parkinson’s Disease FAQ
Our Clinical Trials
Patient Resources
For Investors
& Media
Investor Overview
Stock Information
Stock Quote
Stock Chart
Press Releases
Events and Presentations
Event Calendar
Past Events
Presentations
Corporate Governance
Management
Board of Directors
Committee Composition
Documents & Charters
Contact the Board
Financial Information
SEC Filings
Annual Reports
Analyst Coverage
Investor FAQs
Contact Us
Join
Our Team
Who We Are
Benefits
Join Us
Awards
Contact
Investors & Media
Investor Overview
Stock Information
Stock Quote
Stock Chart
Press Releases
Events and Presentations
Event Calendar
Past Events
Presentations
Corporate Governance
Management
Board of Directors
Committee Composition
Documents & Charters
Contact the Board
Financial Information
SEC Filings
Annual Reports
Analyst Coverage
Investor FAQs
Contact Us
IR Contacts
Primary IR Contact
Paul Cox
VP, Investor Relations
857-201-3463
pcox@vygr.com
